Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GR-1802 by Genrix (Shanghai) Biopharmaceutical for Seasonal Allergic Rhinitis: Likelihood of Approval
GR-1802 is under clinical development by Genrix (Shanghai) Biopharmaceutical and currently in Phase II for Seasonal Allergic Rhinitis. According to...